.png)
Coherence Neuro
Backed by Blackbird · coherenceneuro.com ↗
Coherence Neuro develops therapeutic neurotechnology for cancer. It says the technology works from inside the body, using what it calls internal reprogramming. The company's stated aim is to turn cancer from a terminal illness into a manageable condition.
Why it matters in Australia: Australian venture fund Blackbird has backed Coherence Neuro since its 2023 Seed round.
Backed by
- Blackbird first invested 2023 · Seed Blackbird profile ↗
Similar companies
Accretion Bio
To cure disease, you first have to see it. We watch single molecules move inside living neurons in real time - revealing how brain disease begins, and how to stop it.
Andromeda
Where technology meets empathy – pioneering the future of human-robot interaction.
Everlab
Marc, Sam, Anshul and Steven are on a mission to help people live longer, healthier lives.
9 roles in Australia
Auggie
Auggie is the AI patient retention platform that turns dormant dental patient lists into recovered revenue.
Currus Biologics
Developing the next generation of CAR-T cell therapies to treat solid cancers.
indi
One connected system for child development care
The summary above was written with AI from the company's own site and its backers' listings, and checked by an editor. Backers, years and rounds are as each fund lists them. Open roles are read daily from the funds' jobs boards.